BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 16, Issue 3, Pages 821-832
Publisher
Wiley
Online
2015-12-09
DOI
10.1111/ajt.13541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis
- (2015) Gang Huang et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Inter- and Intralaboratory Comparison of JC Polyomavirus Antibody Testing Using Two Different Virus-Like Particle-Based Assays
- (2014) Piotr Kardas et al. Clinical and Vaccine Immunology
- Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation
- (2014) N. Elfadawy et al. Clinical Journal of the American Society of Nephrology
- Efficient Uptake of Blood-Borne BK and JC Polyomavirus-Like Particles in Endothelial Cells of Liver Sinusoids and Renal Vasa Recta
- (2014) Jaione Simon-Santamaria et al. PLoS One
- BK Polyomavirus in Solid Organ Transplantation
- (2013) H. H. Hirsch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- mTOR kinase structure, mechanism and regulation
- (2013) Haijuan Yang et al. NATURE
- The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation
- (2013) Nissreen Elfadawy et al. TRANSPLANT INTERNATIONAL
- Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring
- (2013) Claire Borni-Duval et al. TRANSPLANTATION
- Cyclophilin A and Nuclear Factor of Activated T Cells Are Essential in Cyclosporine-Mediated Suppression of Polyomavirus BK Replication
- (2012) Y. J. Li et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Polyomavirus BK Replication inDe NovoKidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study
- (2012) H. H. Hirsch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A unifying model for mTORC1-mediated regulation of mRNA translation
- (2012) Carson C. Thoreen et al. NATURE
- Management of polyomavirus-associated nephropathy in renal transplant recipients
- (2012) Dirk R. J. Kuypers Nature Reviews Nephrology
- Management and Outcome of BK Viremia in Renal Transplant Recipients
- (2012) Puneet Sood et al. TRANSPLANTATION
- Reevaluating and Optimizing Polyomavirus BK and JC Real-Time PCR Assays To Detect Rare Sequence Polymorphisms
- (2011) A. Dumoulin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
- (2010) H. Tedesco Silva Jr. et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy
- (2010) S. Schaub et al. AMERICAN JOURNAL OF TRANSPLANTATION
- 1-O-Hexadecyloxypropyl Cidofovir (CMX001) Effectively Inhibits Polyomavirus BK Replication in Primary Human Renal Tubular Epithelial Cells
- (2010) C. H. Rinaldo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The BK virus in renal transplant recipients—review of pathogenesis, diagnosis, and treatment
- (2010) Vikas R. Dharnidharka et al. PEDIATRIC NEPHROLOGY
- A Suppressive Effect of Cyclosporine A on Replication and Noncoding Control Region Activation of Polyomavirus BK Virus
- (2010) Yi-Jung Li et al. TRANSPLANTATION
- Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection
- (2010) Abdelhamid Liacini et al. TRANSPLANTATION
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
- (2009) Bertram L. Kasiske et al. KIDNEY INTERNATIONAL
- Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States
- (2009) Jesse D. Schold et al. TRANSPLANT INTERNATIONAL
- The Decade of Polyomavirus BK-Associated Nephropathy: State of Affairs
- (2009) Emilio Ramos et al. TRANSPLANTATION
- An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States
- (2009) Vikas R. Dharnidharka et al. TRANSPLANTATION
- Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression
- (2008) E. Bernhoff et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Polyomavirus BK Replication DynamicsIn VivoandIn Silicoto Predict Cytopathology and Viral Clearance in Kidney Transplants
- (2008) G. A. Funk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology
- (2008) Rainer Gosert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vitroeffect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells
- (2008) P.D. Acott et al. Transplant Infectious Disease
- Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells
- (2008) Philip Acott et al. TRANSPLANT INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started